Log in to save to my catalogue

1522 Revitalizing systemic immune responses in progressive NSCLC using FLT3L and SBRT

1522 Revitalizing systemic immune responses in progressive NSCLC using FLT3L and SBRT

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_82d8c6fad55140779770b8cfcd282fbd

1522 Revitalizing systemic immune responses in progressive NSCLC using FLT3L and SBRT

About this item

Full title

1522 Revitalizing systemic immune responses in progressive NSCLC using FLT3L and SBRT

Publisher

London: BMJ Publishing Group Ltd

Journal title

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 2), p.A1747-A1748

Language

English

Formats

Publication information

Publisher

London: BMJ Publishing Group Ltd

More information

Scope and Contents

Contents

BackgroundFms-like tyrosine kinase 3 ligand (FLT3L) is a potent hematopoietic growth factor that mobilizes stem cells and increases the number of circulating dendritic cells (DCs) in blood and organs. In a murine lung adenocarcinoma model, FLT3L had modest activity as monotherapy but demonstrated synergy when combined with high-dose radiotherapy.1...

Alternative Titles

Full title

1522 Revitalizing systemic immune responses in progressive NSCLC using FLT3L and SBRT

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_82d8c6fad55140779770b8cfcd282fbd

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_82d8c6fad55140779770b8cfcd282fbd

Other Identifiers

E-ISSN

2051-1426

DOI

10.1136/jitc-2023-SITC2023.1522

How to access this item